{"cik":1797768,"entityName":"Kinnate Biopharma Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-05-10","val":43504484,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":3940000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3212000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccretionAmortizationOfDiscountsAndPremiumsInvestments":{"label":"Accretion (Amortization) of Discounts and Premiums, Investments","description":"The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-276000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":3364000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4581000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":288000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":237000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":{"label":"Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment","description":"Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.","units":{"USD":[{"end":"2020-12-31","val":83000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":87000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccumulatedOtherComprehensiveIncomeLossNetOfTax":{"label":"Accumulated Other Comprehensive Income (Loss), Net of Tax","description":"Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.","units":{"USD":[{"end":"2020-12-31","val":-9000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-40000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":446601000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":449394000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":128000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2793000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":128000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2800000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":20747031,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":7261364,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":400571000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":386365000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":400203000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":251172000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CapitalUnitsAuthorized":{"label":"Capital Units, Authorized","description":"Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.","units":{"shares":[{"end":"2020-12-07","val":1200000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":365462000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":182389000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsPeriodIncreaseDecrease":{"label":"Cash and Cash Equivalents, Period Increase (Decrease)","description":"Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-2716000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-183073000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2019-12-31","val":76453000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-03-31","val":73737000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"},{"end":"2020-12-31","val":365462000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":182389000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-07","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17"},{"end":"2020-12-31","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-07","val":1000000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17"},{"end":"2020-12-31","val":1000000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1000000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":4000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ComprehensiveIncomeNetOfTax":{"label":"Comprehensive Income (Loss), Net of Tax, Attributable to Parent","description":"Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3941000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-17488000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"DebtSecuritiesAvailableForSaleUnrealizedLossPosition":{"label":"Debt Securities, Available-for-sale, Unrealized Loss Position","description":"Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"DepreciationDepletionAndAmortization":{"label":"Depreciation, Depletion and Amortization","description":"The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":16000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":31000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-1.07,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-0.4,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-1.07,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-0.4,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"EmployeeRelatedLiabilitiesCurrent":{"label":"Employee-related Liabilities, Current","description":"Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":1388000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":896000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"FairValueConcentrationOfRiskInvestments":{"label":"Fair Value, Concentration of Risk, Investments","description":"This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"GainLossOnSaleOfPropertyPlantEquipment":{"label":"Gain (Loss) on Disposition of Property Plant Equipment","description":"Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-58000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":955000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":4815000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":{"label":"Increase (Decrease) in Accounts Payable and Accrued Liabilities","description":"The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":360000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":489000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsReceivableRelatedParties":{"label":"Increase (Decrease) in Accounts Receivable, Related Parties","description":"The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-919000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":156000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-368000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"InvestmentIncomeInterest":{"label":"Investment Income, Interest","description":"Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":212000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":403000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":400571000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":386365000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":7304000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":7793000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermInvestments":{"label":"Long-term Investments","description":"The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":134910000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ManagementFeeExpense":{"label":"Management Fee Expense","description":"Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":92000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-13000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-29000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-169631000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-2674000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-13442000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-3941000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-17457000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":212000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":24000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":4153000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":17481000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-4153000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-17481000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":108000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":142000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"OtherComprehensiveIncomeLossNetOfTax":{"label":"Other Comprehensive Income (Loss), Net of Tax","description":"Amount after tax and reclassification adjustments of other comprehensive income (loss).","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":-31000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OtherNonoperatingIncomeExpense":{"label":"Other Nonoperating Income (Expense)","description":"Amount of income (expense) related to nonoperating activities, classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-379000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":16000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PaymentsToAcquireInvestments":{"label":"Payments to Acquire Investments","description":"The cash outflow associated with the purchase of all investments (debt, security, other) during the period.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":169627000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PaymentsToAcquirePropertyPlantAndEquipment":{"label":"Payments to Acquire Property, Plant, and Equipment","description":"The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":29000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":4000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-07","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17"},{"end":"2020-12-31","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-07","val":200000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17"},{"end":"2020-12-31","val":200000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":200000000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PreferredStockValue":{"label":"Preferred Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":3343000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2975000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PropertyPlantAndEquipmentGross":{"label":"Property, Plant and Equipment, Gross","description":"Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":451000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":370000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2020-12-31","val":368000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":283000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3198000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":12666000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-53329000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-70786000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":128000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2793000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ShortTermInvestments":{"label":"Short-term Investments","description":"Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.","units":{"USD":[{"end":"2020-12-31","val":31398000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":65808000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-17486000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-21296000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"},{"end":"2020-12-31","val":393267000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":378572000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"StockholdersEquityNoteStockSplitConversionRatio1":{"label":"Stockholders' Equity Note, Stock Split, Conversion Ratio","description":"Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.","units":{"pure":[{"end":"2020-11-25","val":0.81003,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"UnrealizedGainLossOnInvestments":{"label":"Unrealized Gain (Loss) on Investments","description":"Amount of unrealized gain (loss) on investment.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-31000,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":3672446,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":3672446,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":43477439,"accn":"0001140361-21-017673","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}}}}}